Randomized phase II/III trial of gemcitabine plus nab-paclitaxel versus concurrent chemoradiotherapy with S-1 as neoadjuvant treatment for borderline resectable pancreatic cancer: GABARNANCE study.

Authors :: Ikeda, Masafumi
Nomura, Shogo
Kobayashi, Tatsushi
Kimura, Yasutoshi
Morinaga, Soichiro
Toyama, Hirochika
Sugiura, Teiichi
Hirano, Satoshi
Shimizu, Yasuhiro
Tomikawa, Moriaki
Sadamori, Hiroshi
Katanuma, Akio
Horie, Yoshiki
Unno, Michiaki
Sugimachi, Keishi
Yamaguchi, Hironori
Kojima, Motohiro
Akimoto, Tetsuo
Uesaka, Katsuhiko
Takahashi, Shinichiro
Source :: Journal of Clinical Oncology; 2024 Supplement 17, Vol. 42, pLBA4014-LBA4014, 83p
Publication Year :: 2024

Full Text Access

Tools